Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-07
2008-08-05
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S368000
Reexamination Certificate
active
07407960
ABSTRACT:
Disclosed are novel heterocyclic compounds having the structurewhich are useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.
REFERENCES:
patent: 4788306 (1988-11-01), Schiehser et al.
patent: 6573264 (2003-06-01), Zablocki et al.
patent: 2001/0047000 (2001-11-01), Wolff et al.
patent: 2002064576 (2002-08-01), None
Sato et al. Chem.Pharm. Bull. vol. 20,pp. 905-917 (1972).
McCormick et al. Gen Pharmac. vol. 30, p. 639-645 (1998).
Zacharowski et al. European Journal of Pharmacology, vol. 418, p. 105-110 (2001).
Elzein Elfatih
Koltun Dmitry
Zablocki Jeff
Beck Michael J.
Bernhardt Emily
CV Therapeutics Inc.
Lewis Brian
LandOfFree
Substituted heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3997434